Table 1

Patients' data, outcome of treatment

PatientsTreatment group
CiprofloxacinPlacebo
Number included711
Sex M/F2/58/3
Age (years) median (range)33 (18–52)45 (26–72)
HLA-B27 positive23
Duration of disease (years, (SD))1.9 (1.4)2.0 (1.5)
Cure65
Partial clinical cure12
Failure02
Not evaluable02